Dylan Kennett – DLA Piper

Dylan is a Senior Associate in the London Corporate department of DLA Piper.  He has deep expertise in venture capital, as well as domestic and cross-border mergers & acquisitions and private equity transactions.  He is a trusted advisor for fast growing companies and helping them ‘go global’. His practice encompasses the cannabis, life sciences, technology, media and sport sectors.

Dylan is Co-Head of DLA Piper’s Global Cannabis Practice. The practice sits as a sub-group under the firm’s Life Sciences sector and provides full-service advice with specialist cannabis sector knowledge in over 20 countries globally across DLA Piper.  The practice serves cannabis clients across a wide spectrum of issues, but has particular expertise in cross-border M&A, private and public equity financing, as well as deep expertise in the rapidly evolving global regulatory frameworks.

Dylan is also a Co-Head of DLA Piper’s Emerging Growth and Venture Capital practice.  He has a wealth of experience in advising high growth companies in relation to their fundraising activities, as well as acting for investors, particular corporate venture arms, on their strategic investments and R&D.

Recent Articles

• https://www.forbes.com/sites/dylankennett1/
• https://lifesciences.dlapiper.com/u/102f5s1/dylan-kennett

Key Matters

• Robin Emerson on branding and licensing agreement with leading CBD API company Brains Bioceutical, that will see his daughter’s name used in a new line of CBD products.  DLA Piper also advised Robin as new head of Corporate Social Responsibility at Brains.
• Hanway Associates, the cannabis consultancy business, on the sale of HAPP Holdings Limited to NOBL Group, including the market leading conference series Cannabis Europa.
• Avicanna, a medicinal cannabis licenced producer, on all aspects of their global expansion.
• Phytome Life Sciences, a medicinal cannabis R&D company, on all aspects of their business from their startup financing, regulatory and all other day to day matters.
• Materia Ventures on its European expansion plans.
• Charlotte’s Web, one of the leading CBD brands, on their expansion globally.
• Pet Releaf, a leading pet health company, focussed on cannabis-infused products for animals, on their global expansion.

Social

• Linkedin